The National Comprehensive Cancer Network recognizes National Cancer Fatigue Awa...( ROCKLEDGE PA April 3 2002 In its co...),Health

ROCKLEDGE, PA, April 3, 2002 In its continuing effort to improve care for cancer patients, the National Comprehensive Cancer Network (NCCN) recently announced the release of its new Cancer and Treatment-Related Anemia Practice Guidelines for physicians and its Cancer-Related Fatigue Treatment Guidelines for Patients.

The NCCN Cancer and Treatment-Related Anemia Guidelines were developed to assist clinicians in making decisions about when and how to treat cancer and treatment-related anemia. In particular, these guidelines focus on the type of anemia associated with chronic disease and review the available data guiding the use of erythropoietin in these patients. said Paul Sabbatini, MD, Assistant Attending Physician in the Developmental Chemotherapy Service at Memorial Sloan-Kettering Cancer Center and chairman of the NCCN Anemia Guidelines Panel.

Anemia may be caused by a variety of factors. In cancer patients, it often occurs in the setting of normal serum iron levels and is associated with inappropriately low serum erythropoietin production. Symptoms of anemia in patients range from shortness of breath, rapid heartbeat, and dizziness to inability to concentrate, weakness and fatigue. Available data support the concept that fatigue in patients with cancer is a multifactorial entity, and anemia represents a treatable subset of a very complex problem. Prior to the development of erythropoietin, the only way to treat patients with cancer and treatment-related anemia was with transfusion. The availability of erythropoietin provides a transfusion alternative in certain settings, and provides the ability to maintain hemoglobin in the normal range.

The NCCN guidelines recommend that patients with hemoglobin levels of < 11 g/dl enter the screening portion of the algorithm. If immediate correction with transfusion is not necessary, the pathways guide the clinician through an assessment of the potential risk of requiring transfusion, as well as an
'"/>

Contact: Todd Ringler
617-577-8110
Feinstein Kean Healthcare
3-Apr-2002

Page: 1 2
Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. National Academies News: William H. Foege to receive Public Welfare Medal, Academys highest honor
3. National Academies news: Academy honors 17 for major contributions to science
4. National Academies advisory: Report assesses health implications of perchlorate exposure
5. National Academies Advisory: Jan. 11 public briefing on perchlorate in drinking water
6. National Academies news: Gulf War and Health
7. National survey shows few physicians elected to Congress
8. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
9. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research
10. National Academies advisory: Nov. 4-6 Frontiers of Science meeting in Irvine, Calif.
11. National Chemistry Week celebrates health and wellness in Washington, D.C., area